Home About us Current issue Ahead of Print Back issues Submission Instructions Advertise Contact Login   

Search Article 
Advanced search 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 2557 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

    Article Cited by others


Use of iron sucrose in dialysis patients sensitive to iron dextran

Haddad Ayham, Abbadi Rabe«SQ»a, Marji Ann

Year : 2009| Volume: 20| Issue : 2 | Page no: 208-211

   This article has been cited by
1 Use of intravenous iron supplementation in chronic kidney disease: An update
Macdougall, I.C. and Geisser, P.
Iranian Journal of Kidney Diseases. 2013; 7(1): 9-22
[Pubmed]  [Google Scholar]
2 Differences between the original iron sucrose complex venofer and the iron sucrose similar sucrofer
Shah, G.B. and Chorawala, M.C. and Trivedi, V.R. and Deshpande, S.S.
Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2013; 4(1): 655-669
[Pubmed]  [Google Scholar]
3 Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease [Sicherheitsaspekte parenteraler Eisentherapien bei Patienten mit chronischer Niereninsuffizienz]
Potthoff, S.A. and Münch, H.G.
Deutsche Medizinische Wochenschrift. 2013; 138(24): 1312-1317
[Pubmed]  [Google Scholar]
4 A comparative look at the safety profiles of intravenous iron products used in the hemodialysis population
Coppol, E. and Shelly, J. and Cheng, S. and Kaakeh, Y. and Shepler, B.
Annals of Pharmacotherapy. 2011; 45(2): 241-247
[Pubmed]  [Google Scholar]


Read this article